Biocon informs about press release

23 Nov 2017 Evaluate

Biocon has informed about Press Release titled ‘Biocon Launches KRABEVA- Biosimilar Bevacizumab for Treating Several Types of Cancer in India.’

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

365.25 -1.15 (-0.31%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×